scorecardresearch
Thursday, July 24, 2025
TopicCSIR

Topic: CSIR

CSIR set to seek emergency use approval for sepsis drug Sepsivac repurposed for treating Covid

Licensed for use in sepsis, Sepsivac has shown good results in phase 2 and 3 trials in serious Covid-19 patients. A separate study is also testing the drug as a vaccine.

PM Modi lauds scientists for developing ‘made-in-India’ Covid vaccines within a year

Addressing a CSIR meeting, PM Modi reiterated his call for 'Aatmanirbhar Bharat', saying the Covid crisis may have slowed its pace but the resolve remains the same.

Next waves could hit children, teens more but there is no need to panic, govt expert says

Dr Anurag Agrawal, director, Institute of Genomic and Integrative Biology, also says it’s absolutely imperative that the government prepares for a third wave. 

New Covid lineage B.1.618 identified from Bengal, 2nd in India after ‘double mutant’ virus

CSIR-IGIB’s Vinod Scaria says lineage was found last October and is increasing in proportion in Bengal, but can’t be sure if it’s driving Covid spike.

People have to ensure there is no third wave of Covid, says CSIR Director General

The DG of the Council of Scientific and Industrial Research, Dr Shekhar Mande, said people have to exercise self-discipline and self-regulation to beat the pandemic.

How a bacteria is helping revive an endangered ayurvedic herb in CSIR labs

In Ayurveda, Picrorhiza kurroa or kutki is used for treatment of digestive disorders & for improving immunity. The herb was listed as rare and endangered in 1997.

After FELUDA, CSIR develops paper test ‘RAY’ to identify Covid variants within an hour

Paper-based RAY test is much quicker than genome sequencing and can identify three variants with the common mutation N501Y from UK, South Africa, and Brazil.

CSIR in talks to bring Moderna’s Covid vaccine to India, says its chief Shekhar Mande

Mande says current talks are scientific, and once CSIR’s Hyderabad-based CCMB understands Moderna’s mRNA technology, it can produce the vaccine ‘within weeks’.

Smoking can’t protect against Covid, it makes antibodies disappear — Experts on CSIR study

A CSIR study said smokers had low seroprevalence. But doctors said smoking reduces immunity, which makes antibodies disappear faster — which is why seroprevalence may be lower.

Off The Cuff with Shekhar C. Mande

In conversation with ThePrint’s Editor-in-Chief Shekhar Gupta at Off The Cuff, Shekhar Mande, Director, Council of Scientific and Industrial Research, discussed his study that...

On Camera

Defence, tech, education—Modi’s visit will boost India-UK ties

Given the immediate challenges on India’s borders, cooperation in the defence sector with partners such as the UK has achieved greater importance.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Indian firm sets up titanium, superalloy plants to meet global need. Safran, Dassault, BAE line up

PTC Industries is investing Rs 1,000 cr in 4 manufacturing plants in UP, has already started supplying titanium parts to BAE Systems for its M-777 howitzers that India also uses.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.